AVITA Medical, Inc. financial data

Symbol
RCEL on Nasdaq, AVHHL on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
28159 Avenue Stanford, Suite 220, Valencia, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Avita Therapeutics, Inc. (to 12/10/2020), Avita Medical, Ltd. (to 6/30/2020)
Latest financial report
Q1 2024 - May 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 673 % -24.7%
Quick Ratio 39.8 % +76.8%
Debt-to-equity 74.9 % +426%
Return On Equity -84.1 % -173%
Return On Assets -47.6 % -77.3%
Operating Margin -98.5 % -32%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.8 M shares +1.86%
Common Stock, Shares, Outstanding 25.8 M shares +1.82%
Entity Public Float 432 M USD +268%
Common Stock, Value, Issued 3 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 25.6 M shares +1.73%
Weighted Average Number of Shares Outstanding, Diluted 25.6 M shares +1.73%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 50.7 M USD +35.4%
Cost of Revenue 7.63 M USD +28.6%
Research and Development Expense 21.4 M USD +44.6%
Selling and Marketing Expense 43.4 M USD +83.7%
General and Administrative Expense 29 M USD +20.4%
Operating Income (Loss) -50 M USD -78.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.8 M USD -69.8%
Income Tax Expense (Benefit) 66 K USD +6.45%
Net Income (Loss) Attributable to Parent -44.8 M USD -69.6%
Earnings Per Share, Basic 1.04 USD/shares +225%
Earnings Per Share, Diluted 1.04 USD/shares +225%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 17 M USD -39.6%
Marketable Securities, Current 51.2 M USD +12.8%
Accounts Receivable, after Allowance for Credit Loss, Current 7.08 M USD +57.3%
Inventory, Net 7.17 M USD +155%
Other Assets, Current 135 K USD +366%
Assets, Current 86 M USD +3.9%
Property, Plant and Equipment, Net 4.3 M USD +222%
Operating Lease, Right-of-Use Asset 3.28 M USD +80.4%
Intangible Assets, Net (Excluding Goodwill) 542 K USD +17.6%
Other Assets, Noncurrent 401 K USD +74.3%
Assets 97.4 M USD +5.14%
Liabilities, Current 11.9 M USD +3.27%
Contract with Customer, Liability, Noncurrent 349 K USD -8.64%
Operating Lease, Liability, Noncurrent 2.53 M USD +105%
Other Liabilities, Noncurrent 715 K USD +42.1%
Liabilities 64 M USD +348%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.07 M USD -139%
Retained Earnings (Accumulated Deficit) -317 M USD -16.5%
Stockholders' Equity Attributable to Parent 32.6 M USD -58%
Liabilities and Equity 97.4 M USD +5.14%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.9 M USD -130%
Net Cash Provided by (Used in) Financing Activities 631 K USD +269%
Net Cash Provided by (Used in) Investing Activities 15.1 M USD -19.8%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 25.8 M shares +1.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.17 M USD -152%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 17 M USD -39.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.36 K USD +33775%
Deferred Tax Assets, Valuation Allowance 63.3 M USD +12%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 63.9 M USD +12.7%
Operating Lease, Liability 3.44 M USD +83.4%
Depreciation 657 K USD +29.6%
Payments to Acquire Property, Plant, and Equipment 1.15 M USD +304%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -55.7 M USD -112%
Lessee, Operating Lease, Liability, to be Paid 4.03 M USD +91%
Operating Lease, Liability, Current 903 K USD +41.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.13 M USD +155%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.17 M USD +57.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +25.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 593 K USD +151%
Lessee, Operating Lease, Liability, to be Paid, Year Three 657 K USD +74.3%
Deferred Tax Assets, Operating Loss Carryforwards 50.4 M USD +4.18%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 66 K USD +83.3%
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 190 K USD
Operating Lease, Payments 903 K USD +11.5%
Additional Paid in Capital 353 M USD +3.16%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 66 K USD +83.3%
Amortization of Intangible Assets 43 K USD +30.3%
Depreciation, Depletion and Amortization 203 K USD +50.4%
Deferred Tax Assets, Net of Valuation Allowance 624 K USD +160%
Share-based Payment Arrangement, Expense 8.34 M USD +24.3%
Interest Expense 2.5 M USD +33800%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%